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Abstract
In biospectroscopy, suitably annotated and statistically independent samples (e. g. patients, batches, etc.) for classifier training and
testing are scarce and costly. Learning curves show the model performance as function of the training sample size and can help to
determine the sample size needed to train good classifiers. However, building a good model is actually not enough: the performance
must also be proven. We discuss learning curves for typical small sample size situations with 5 – 25 independent samples per class.
Although the classification models achieve acceptable performance, the learning curve can be completely masked by the random
testing uncertainty due to the equally limited test sample size. In consequence, we determine test sample sizes necessary to achieve
reasonable precision in the validation and find that 75 – 100 samples will usually be needed to test a good but not perfect classifier.
Such a data set will then allow refined sample size planning on the basis of the achieved performance. We also demonstrate how
to calculate necessary sample sizes in order to show the superiority of one classifier over another: this often requires hundreds of
statistically independent test samples or is even theoretically impossible. We demonstrate our findings with a data set of ca. 2550
Raman spectra of single cells (five classes: erythrocytes, leukocytes and three tumour cell lines BT-20, MCF-7 and OCI-AML3) as
well as by an extensive simulation that allows precise determination of the actual performance of the models in question.
Keywords: small sample size, design of experiments, multivariate, learning curve, classification, training, validation
This paper has been published as
C. Beleites, U. Neugebauer, T. Bocklitz, C. Krafft and
J. Popp: Sample size planning for classification mod-
els. Analytica Chimica Acta, 2013, 760 (Special Is-
sue: Chemometrics in Analytical Chemistry 2012), 25–33,
DOI: 10.1016/j.aca.2012.11.007.
The manuscript is also available at arXiv no. 1211.1323,
where the source files contain also the source code shown
in supplementary file II.
Accepted Author Manuscript
1. Introduction
Sample size planning is an important aspect in the design
of experiments. While this study explicitly targets sample size
planning in the context of biospectroscopic classification, the
ideas and conclusions apply to a much wider range of applica-
tions. Biospectroscopy suffers from extreme scarcity of statisti-
cally independent samples, but small sample size problems are
common also in many other fields of application.
In the context of biospectroscopic studies, suitably annotated
and statistically independent samples for classifier training and
validation frequently are rare and costly. Moreover, the classi-
fication problems are often rather ill-posed (e. g. diseased vs.
∗Corresponding author
Email address: Claudia.Beleites@ipht-jena.de (Claudia Beleites)
non-diseased). In these situations, particular classes are ex-
tremely rare, and/or large sample sizes are necessary to cover
classes that are rather ill-defined like “not this disease” or “out
of specification”. In addition, ethical considerations often re-
strict the studied number of patients or animals.
Even though the data sets often consist of thousands of spec-
tra, the statistically relevant number of independent cases is
often extremely small due to “hierarchical” structure of the
biospectroscopic data sets: many spectra are taken of the same
specimen, and possibly multiple specimen of the same patient
are available. Or, many spectra are taken of each cell, and a
number of cells is measured for each cultivation batch, etc. In
these situations, the number of statistically independent cases
is given by the sample size on the highest level of the data hi-
erarchy, i. e. patients or cell culture batches. All these reasons
together lead to sample sizes that are typically in the order of
magnitude between 5 and 25 statistically independent cases per
class.
Learning curves describe the development of the perfor-
mance of chemometric models as function of the training sam-
ple size. The true performance depends on the difficulty of the
task at hand and must therefore be measured by preliminary ex-
periments. Estimation of necessary sample sizes for medical
classification has been done based on learning curves [1, 2] as
well as on model based considerations [3, 4]. In pattern recog-
nition, necessary training sample sizes have been discussed for
a long time (e. g. [5–7]).
However, building a good model is not enough: the quality
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Figure 1: Confusion matrix (a) and characteristic fractions (b)
– (e). The parts of the confusion matrix summed as enumerator
and denominator for the respective fraction with respect to class
A are shaded.
of the model needs to be demonstrated.
One may think of training a classifier as the process of mea-
suring the model parameters (coefficients etc.). Likewise, test-
ing a classifier can be described as a measurement of the model
performance. Like other measured values, both the parameters
of the model and the observed performance are subject to sys-
tematic (bias) and random (variance) uncertainty.
Classifier performance is often expressed in fractions of
test cases, counted from different parts of the confusion ma-
trix, see fig. 1. These ratios summarize characteristic aspects
of performance like sensitivity (SensA: “How well does the
model recognize truly diseased samples?”, fig. 1b), specificity
(SpecA: “How well does the classifier recognize the absence
of the disease?”, fig. 1c), positive and negative predictive val-
ues (PPVA/NPVA: “Given the classifier diagnoses disease/non-
disease, what is the probability that this is true?”, fig. 1d and
1e). Sometimes further ratios, e. g. the overall fraction of cor-
rect predictions or misclassifications, are used.
The predictive values, while obviously of more interest to
the user of a classifier than sensitivity and specificity, cannot
be calculated without knowing the relative frequencies (prior
probabilities) of the classes.
From the sample size point of view, one important difference
between these different ratios is the number of test cases ntest
that appears in the denominator. This test sample size plays a
crucial role in determining the random uncertainty of the ob-
served performance pˆ, (see below). Particularly in multi-class
problems, this test sample size varies widely: the number of test
cases truly belonging to the different classes may differ, leading
to different and rather small test sample sizes for determining
the sensitivity p of the different classes. On contrast, the over-
all fraction of correct or misclassified samples use all tested
samples in the denominator.
The specificity is calculated from all samples that truly do not
belong to the particular class (fig. 1c). Compared to the sensi-
tivities, the test sample size in the denominator of the speci-
ficities is therefore usually larger and the performance estimate
more precise (with the exception of binary classification, where
the specificity of one class is the sensitivity of the other). Thus
small sample size problems in the context of measuring clas-
sifier performance are better illustrated with sensitivities. It
should also be kept in mind that the specificity often corre-
sponds to an ill-posed question: “Not class A” may be any-
thing. Yet not all possibilities of a sample truly not belonging
to class A are of the same interest. In multi-class set-ups, the
specificity will often pool easy distinctions with more difficult
differential diagnoses. In our application [8, 9], the specificity
for recognizing a cell does not come from the BT-20 cell line
pools e. g. the fact that it is not an erythrocyte (which can eas-
ily be determined by eye without any need for chemometric
analysis) with the fact that it does not come from the MCF-7
cell line, which is far more similar (yet from a clinical point
of view possibly of low interest as both are breast cancer cell
lines) and the clinically important fact that it does not belong
to the OCI-AML3 leukemia. This pooling of all other classes
has important consequences. Increasing numbers of test cases
in easily distinguished classes (erythrocytes) will lead to im-
proved specificities without any improvement for the clinically
relevant differential diagnoses. Also, it must be kept in mind
that random predictions (guessing) already lead to specificities
that seem to be very good. For our real data set with five differ-
ent classes, guessing yields specificities between 0.77 and 0.85.
Reported sensitivities should also be read in relation to guessing
performance, but neglecting to do so will not cause an intuitive
overestimation of the prediction quality: guessing sensitivities
are around 0.20 in our five-class problem.
Examining the non-diagonal parts of the confusion table in-
stead of specificities avoids these problems. If reported as frac-
tions of test cases truly belonging to that class, then all elements
of the confusion table behave like the sensitivities on the diag-
onal, if reported as fractions of cases predicted to belong to
that class, the entries behave like the positive predictive values
(again on the diagonal).
Literature guidance on how to obtain low total uncertainty
and how to validate different aspects of model performance is
available [10–14]. In classifier testing, usually several assump-
tions are implicitly made which are closely related to the be-
haviour of the performance measurements in terms of system-
atic and random uncertainty.
Classification tests are usually described as Bernoulli-
process (repeated coin throwing, following a binomial distri-
bution): ntest samples are tested, and thereof k successes (or
errors) are observed. The true performance of the model is p,
and its point estimate is
pˆ =
k
ntest
(1)
with variance
Var
(
k
ntest
)
=
p(1 − p)
ntest
(2)
In small sample size situations, resampling strategies like the
bootstrap or repeated/iterated k-fold cross validation are most
appropriate. These strategies estimate the performance by set-
ting aside a (small) part of the samples for independent test-
ing and building a model without these samples, the surrogate
model. The surrogate model is then tested with the remaining
samples. The test results are refined by repeating/iterating this
2
procedure a number of times. Usually, the average performance
over all surrogate models is reported. This is an unbiased esti-
mate of the performance of models with the same training sam-
ple size as the surrogate models [1, 11]. Note that the observed
variance over the surrogate models possibly underestimates the
true variance of the performance of models trained with ntrain
training cases [1]. This is intuitively clear if one thinks of a sit-
uation where the surrogate models are perfectly stable, i. e. dif-
ferent surrogate models yield the same prediction for any given
case. No variance is observed between different iterations of a
k-fold cross validation. Yet, the observed performance is still
subject to the random uncertainty due to the finite test sample
size of the underlying Bernoulli process.
Usually, the performance measured with the surrogate mod-
els is used as approximation of the performance of a model
trained with all samples, the final model. The underlying as-
sumption is that setting aside of the surrogate test data does
not affect the model performance. In other words, the learning
curve is assumed to be flat between the training sample size of
the surrogate model and training sample size of the final model.
The violation of this assumption causes the well-known pes-
simistic bias of resampling based validation schemes.
The results of testing many surrogate models are usually
pooled. Strictly speaking, pooling is allowed only if the dis-
tributions of the pooled variables are equal. The description
of the testing procedure as Bernoulli process allows pooling if
the surrogate models have equal true performance p. In other
words, if the predictions of the models are stable with respect
to perturbed training sets, i. e. if exchanging of a few samples
does not lead to changes in the prediction. Consequently, model
instability causes additional variance in the measured perfor-
mance.
Here, we discuss the implications of these two aspects of
sample size planning with a Raman-spectroscopic five-class
classification problem: the recognition of five different cell
types that can be present in blood. In addition to the measured
data set, the results are complemented by a simulation which
allows arbitrary test precision.
2. Materials and Methods
2.1. Raman Spectra of Single Cells
Raman spectra of five different types of cells that could be
present in blood are used in this study. Details of the prepa-
ration, measurements and the application have been published
previously [8, 9]. The data were measured in a stratified man-
ner, specifying roughly equal numbers of cells per class before-
hand, and do not reflect relative frequencies of the different cells
in a target patient population. Thus, we cannot calculate predic-
tive values for our classifiers.
For this study, the spectra were imported into R [15] using
package hyperSpec [16]. In order to correct for deviations of
the wavenumber calibration the maximum of the CaF2 band
was aligned to 322 cm-1. The spectra then underwent a smooth-
ing interpolation (spc.loess) onto a common wavenumber
axis ranging from 500 to 1800 and 2600 to 3200 cm-1 with data
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Figure 2: Spectra of the 5 classes: BT-20 breast carcinoma
cells, MCF-7 breast carcinoma cells, OCI-AML3 leukemia
cells, normal leukocytes and normal erythrocytes (from top to
bottom). Shown are the median and the 5th to 95th percentile
spectra. The confusion tables are available as supplementary
material.
point spacing of 4 cm-1. Baseline correction was performed in
the high wavenumber region by a third order polynomial fit to
spectral regions where no CH stretching signals occur (2700
– 2825, 3020 – 3040 and 3085 – 3200 cm-1) which was then
used as baseline for the CH stretching bands from 2810 to 3085
cm-1. A third order polynomial automatically selecting support
points between 500 – 1200 cm-1 was blended smoothly with a
quadratic polynomial in the spectral range automatically select-
ing support points between 800 – 1200 and 1700 – 1800 cm-1.
After baseline correction, the spectral ranges 600 – 1800 and
2810 – 3085 cm-1 were retained. Finally, the spectra were area
normalized.
Figure 2 shows the preprocessed spectra. Erythrocyte (red
blood cells, rbc) spectra can easily be recognized by the reso-
nance enhanced characteristic signature of hemoglobin around
1600 cm-1. Leukocyte (leu) spectra are rather similar to the tu-
mour cell spectra, yet there are subtle differences in the shape of
the CH2-deformation vibrations around 1440 cm
-1, the inten-
sity of the νCH stretching vibrations (2810 – 3085 cm-1) which
are more intense in the tumour cells, and the intensity of the
phenylalanine band at 1002 cm-1 (less intense in the tumour
cells). Between the different tumour cell lines (bt, mcf, and oci)
no distinct marker bands are visible by eye.
Variation in the data set is introduced by using cells from
5 different donors (leukocytes and erythrocytes) and 5 different
cultivation batches, respectively; measuring the cells on the first
day of preparation and one day after (yielding 9 measurement
days) and using two different lasers of the same model from the
same manufacturer. For the present study, we pretend not to
know of these influencing factors and treat the spectra as inde-
pendent. This allows us to pretend that we have a sufficiently
large data set to run reference calculations that can be used as
ground truth. The consequence is that no performance for the
recognition of the cell lines in general can be inferred from this
study: the results would be heavily overoptimistic (tab. 1, see
3
class cell type nspectra sensitivity
sim. LDA sim. PLS-LDA real PLS-LDA real PLS-LDA batch-wise
rbc erythrocytes 372 1.00 1.00 0.99 (0.96 – 0.99) 0.97 (0.96 – 0.98)
leu leukocytes 569 1.00 0.99 0.97 (0.96 – 0.97) 0.87 (0.84 – 0.90)
mcf MCF-7 breast carc. 558 0.95 0.87 0.91 (0.90 – 0.92) 0.31 (0.24 – 0.42)
bt BT 20 breast carc. 532 0.91 0.72 0.75 (0.74 – 0.76) 0.38 (0.32 – 0.45)
oci OCI-AML3 leukemia 518 0.94 0.86 0.89 (0.88 – 0.90) 0.30 (0.23 – 0.17)
Table 1: Data set characteristics: classes, number of spectra per class and “best possible” sensitivities. For the simulated (sim.) data
(column “sim. LDA” and “sim. PLS-LDA”), ntest = 2 · 104 spectra. Best possible performance of the real data was estimated using
100× 5-fold cross validation, shown are average and 5th to 95th percentile of observed sensitivities over the iterations. Column “real
PLS-LDA” corresponds to the setup for this study, treating each spectrum as independent of the other spectra, for column 7 (“real
PLS-LDA batch-wise”) the validation splits patients and batches rather than spectra.
also [14] for a discussion of representative testing).
Hence, we have a data set of about 2500 spectra (tab. 1)
of five classes with “unknown” influencing factors. The dif-
ficulty in recognising the five different classes varies widely:
while erythrocytes are extemely easy to recognize, we expect
that perfect recognition of leukocytes is possible as well though
we expect that more training cases are needed to achieve this.
Differential diagnosis of the cancer cell lines is more difficult,
and substantial overlap between the two breast carcinoma cell
lines BT-20 and MCF-7 has been observed in previous stud-
ies [8, 9]. Throughout this paper, we discuss the sensitivities
for erythrocytes (rbc), leukocytes (leu) and the tumour cell line
BT-20 (bt).
Of these 2500 spectra, we draw data sets of size 25
cases / class keeping the remaining spectra as a large test set to
get a more precise estimate of the performance of the respective
models.
rbc is the smallest class, its sensitivity can be estimated with
a precision better than ± 0.052 (95 % confidence interval at sen-
sitivity of 0.5).
2.2. Simulated Spectra
In addition to the experimental data set, simulations were
used. This allows to study an idealized situation: arbitrarily
large test sets allow to measure the true performance with neg-
ligible random uncertainty due to the testing. Thus, the random
uncertainty due to model instability can be measured with the
simulations while these two sources of random uncertainty can-
not be separated for the real data.
For each of the five classes in the experimental data set, av-
erage spectrum and covariance matrix were calculated. Multi-
variate normally distributed simulated spectra were simulated
using rmvnorm [17, 18]. Briefly, the Mersenne-Twister algo-
rithm generates uniformly distributed pseudo-random numbers
which are then converted to normally distributed random num-
bers via the inverse cumulative distribution function. The re-
quested covariance structure is obtained by multiplying with the
matrix root of the covariance matrix (calculated via eigenvalue
decomposition) and the requested mean spectrum is added.
100 “small” data sets of 25 spectra / class (i. e. 125 spec-
tra of all classes together per small dataset) were generated.
For determining the real performance of the models, a large
test set of 4 · 104 spectra / class was generated. This means that
the sensitivities can be measured with a precision of better than
0.5 ± 0.005 (95 % c.i.), the standard deviation of observed per-
formance is then σ(pˆ) =
√
p(1−p)
n ≤ 0.5√n = 0.0025.
In addition, one large training set of 2 · 104 spectra / class was
generated. This data set was used to estimate the best possible
performance that can be obtained with the chosen classifiers on
this idealized problem.
2.3. Classification Models
As classifier we chose PLS-LDA as implemented in package
cbmodels[19] where the partial least squares (PLS) and linear
discriminant analysis (LDA) models from packages pls[20] and
MASS[21] are combined into one model. The projection by the
PLS is a suitable variable reduction for LDA [22]. LDA mod-
els trained on the PLS scores suffer much less from instability
than LDA models trained on data with large numbers of vari-
ates. The number of latent variables was set to 10 for ntrain ≥ 4
training spectra / class. For the extremely small training sets, it
was restricted to be at most half the total number of spectra in
the training set. All classification models were trained with all
five classes.
In addition, we built two models using 2 · 104 simulated spec-
tra / class and tested them with the large test set (4 · 104 spec-
tra / class). These models are assumed to achieve the best pos-
sible performance LDA can reach with and without PLS di-
mensionality reduction for the given problem. The achieved
sensitivities are 1.00 for rbc and leu and 0.91 for bt (column
“sim. LDA” in tab. 1) without PLS. The 10 latent variable PLS-
LDA model trained on the same data set had lower sensitivities
of 1.00 for the rbc, 0.99 for leu, and 0.72 for class bt (column
“sim PLS-LDA”).
For the real data, we report best possible performance for
PLS-LDA models of the complete data set using 10 latent vari-
ables (measured by 100× iterated 5-fold cross validation, col-
umn “real PLS-LDA”). In addition, we checked the perfor-
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mance for 100× iterated 5-fold cross validation when the vali-
dation splits are done by patient/batch (as the underlying struc-
ture of the measurement would require; column “real PLS-LDA
batch-wise”). Here, 10 latent variable PLS-LDA can still per-
fectly recognize erythrocytes, sensitivities for leukocytes are
close to 0.90, but among the tumour cell lines the model is basi-
cally guessing. 10 latent variable PLS-LDA is an extremely re-
strictive model set-up which is appropriate for the small sample
sizes studied in this paper but recognition of circulating tumour
cells requires more elaborate modelling [8, 9].
The interested reader will find the confusion tables, i. e. sen-
sitivities as well as the specificities for the various types of mis-
classification, in the supplementary material.
2.4. Validation Set-Up
Iterated k-fold cross validation was chosen as validation
scheme. While out-of-bootstrap validation is sometimes pre-
ferred for small sample sizes due to the lower variance, a previ-
ous study on spectroscopic data sets found comparable overall
uncertainty for these two validation schemes [13]. In contrast to
k-fold cross validation, the effective training sample size is not
known in out-of-bootstrap validation. Out-of-bootstrap usually
has the same nominal training sample size as the whole data
set. However, it is pessimistically biased with respect to the fi-
nal model. Such a pessimistic bias is usually observed if the
training set is smaller than the whole data set. This pessimistic
bias is usually larger than that of 5- or 10-fold cross validation.
This suggests that the duplicate cases in the bootstrap training
sets do not contribute as much information for classifier train-
ing as the first instance of the given case does. Cross validation
is unbiased with respect to the number of cases actually used
for training of the surrogate models [11] and is therefore more
suitable for calculating learning curves.
We used k = 5-fold cross validation with 100 iterations.
2.5. Growing Data Sets or Retrospective Learning Curves
Both real and simulated data sets were used for the learning
curve estimation in a “growing” fashion. This simulates a sce-
nario where at first very few cases are available, and new, better
models are built as further cases become available, following
the practice of modeling and sample collection we usually en-
counter.
100 such growing data sets were analysed for both the real
and the simulated data. This allows calculation of the average
performance that can be expected for our cell classifier with
10 latent variable PLS-LDA models as well as the respective
random uncertainty.
The alternative to the growing data set scenario, retrospective
calculation of the learning curve, would lead to an intermediate
between the two different learning curves: as there are many
possibilities to draw few cases out of even a small data set, for
the very small sample sizes the resulting curve will be closer
to the average performance of that training sample size. How-
ever, as the drawn number of samples approaches the size of the
small data set, the retrospective estimate of the learning curve
tends towards the estimate of the growing data set.
3. Learning Curves
The learning curve describes the performance of a given
classifier for a problem as function of the training sample size
[10]. The prediction errors a classifier makes may be divided
into four categories:
1. the irreducible or Bayes error
2. the bias due to the model setup,
3. additional systematic deviations (bias), and
4. random deviations (variance)
The best possible performance that can be achieved with a given
model setup consists of the Bayes error, i. e. the best possi-
ble performance for the best possible model, and the bias for
ntrain → ∞. The latter two components depend on the training
sample size, and tend to zero as more cases become available.
The general discussion of learning curves, e. g. [10, fig. 7.8],
usually considers the combination of the first three error types
(as function of the training sample size) which form the av-
erage (expected) performance of a given classification rule for
a particular problem if ntrain training cases are available. The
learning curve for a particular data set is known as conditional
learning curve [10].
In the context of classification based on microarray data, both
empirically fitted functions [1] and parametric methods based
on the difference in gene expression [3, 4] have been used to es-
timate learning curves and necessary sample sizes for the train-
ing of well performing classifiers. An extension of Mukherjee
et al. [1] has been applied to medical text classification [2].
Microarray (gene expression) data sets are similar to biospec-
troscopic data sets in their shape and size: in both cases the raw
data typically consists of thousands of measurement channels
(variates: genes, wavelengths) and typically hundreds to thou-
sands of rows (expression profiles, spectra). However, they dif-
fer from typical biospectroscopic data sets in two important as-
pects. Firstly, biospectroscopic data sets often have rather large
numbers of spectra of the same patient or batch while multi-
ple measurements of the same subject are far less common in
microarray studies. The data sets in Mukherjee et al. [1] have
total patient numbers between 53 and 78 (plus one large set of
280 patients), these sample sizes unfortunately do not allow to
check their extrapolated predictions of the performance. Sec-
ondly, the information with respect to the classification problem
is usually spread out over wide spectral ranges in biospectro-
scopic classification. In contrast, microarray classification typ-
ically relies on rather few genes that carry information among a
large number of noise-only variates [3, 4].
Figures 3 and 4 give the (unconditional) learning curves for
the real and simulated data in the top rows (lines). With smaller
sample sizes, the random uncertainty grows, and cannot be ne-
glected: A particular data set of size ntrain may differ substan-
tially from the average data set of size ntrain. For each training
sample size, 90 of the 100 small data sets had performance in-
side the shaded area.
For the simulated data, one such growing data set is shown
exemplarily in the middle (true performance, i. e. tested with
the large test set) and bottom rows (cross validation estimate of
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Figure 3: Learning curves of the real data set: sensitivities for recognition of red blood cells (rbc), leukocytes (leu), and BT-20
breast tumour cell line (bt). Black: Sensitivity observed for 100 iterations of 5-fold cross validation on the complete data set,
approximating the best possible performance of a 10 latent variable PLS-LDA on this data set. Lines give the average, the shaded
area covers the 5th to 95th percentile of iterations (bottom and middle row) and small data sets (top row). Thin lines: average “one
set large” and “one set cv” (cross validation) performance are repeated in the rows above for easier comparison. Colours: blue
performance measured with large test set, red performance measured by iterated cross validation. Bottom row: Learning curve of
one growing data set, measured with 100× iterated 5-fold cross validation. Middle row: The same models as in the bottom row, but
performance measured with large test set. The percentiles depict the instability of the surrogate models trained during iterated cross
validation, but are subject only to low uncertainty due to the finite test sample size. Top row: sensitivity achieved for 100 different
small data sets of size ntrain, measured with the large test set.
performance of the same model) of fig. 4. The example run per-
forms exceptionally well for the leukocytes but roughly at the
5th percentile with respect to all possible data sets of size ntrain
of sensitivity for red blood cells and the BT-20 cell line. The
example run of the real data (fig. 3) in general follows more
closely the average sensitivity of data sets of the respective
size. Learning curves reported for real data sets usually give
one point measurement for each classifier set up and training
sample size only and are usually calculated in the “retrospec-
tive” manner according to our definition above.
For the planning of necessary sample sizes needed to train
good classifiers, both the expected performance in the top row
of figs. 3 and 4 and the performance for a given growing data set
as in the middle rows are of importance. The top rows answer
the question how many samples should be collected if no sam-
ples are yet available for a specific problem, while the middle
rows belong to the question how many more samples in addition
to the already available ones should be collected.
In practice, however, neither the top nor the middle row
learning curves are available, only (iterated) cross validation or
out-of-bootstrap results are available from within a given data
set. The results of the cross-validation in the bottom row are an
unbiased estimate of the middle row (we use the actual training
sample size of the surrogate models, i. e. 45 of the sample size
of the small data set). However, the cross validation is subject
to much higher random uncertainty, as the total number of test
cases is much lower than with the large test set used to calculate
the middle rows.
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Figure 4: Learning curves of the simulated data set. This plot was generated analogously to fig 3. The only difference is that the
best possible error (black lines) was measured with the large independent test set, see description of the data analysis.
As explained before, the random uncertainty comes from two
sources: firstly, model instability, i. e. differences between sur-
rogate models built with different training sets of the same size,
and secondly testing uncertainty due to the finite number of
spectra available for testing. The first is related to the number
of training samples while the second depends on the number of
test samples. Testing with the large test set reduces the second
source of uncertainty but does not influence the variation due
to model instability. The only difference between middle and
bottom rows in figs. 3 and 4 are the test sets: exactly the same
models are tested with the large test set (middle) and the spectra
held out by the cross validation (bottom row). In other words,
the bottom row is a “small test sample size” approximation to
the middle row. The simulations use ntest = 2 · 104 for refer-
ence (top and middle row), meaning that the variation depicted
in middle row of fig. 4 is caused only by model instability. On
contrast, for the real data, only ca. 350 – 540 reference test
spectra are available and uncertainty due to the finite test sam-
ple size can contribute substantially to the observed variation in
the middle row of fig. 3. However, the total random uncertainty
on the iterated cross validation is dominated by the huge ran-
dom uncertainty due to testing only with the up to 25 samples
of the small data set.
This uncertainty is large enough to mask important features
of the learning curve of the growing data set: in our example run
for the simulated data, the sensitivity for erythrocytes is largely
overestimated (other runs show equally large underestimation).
The exceptionally good performance for the leukocytes with 4 –
10 training samples is not only not detected by the cross valida-
tion but in fact two dips appear in the cross validation estimate
of the example data set’s learning curve. For the BT-20 cell
line, we observe an oscillating behaviour with the addition of
single cases up to a data set size of 9 samples (i. e. on aver-
age 7.2 training samples). Of course, we observe also runs that
match the true (reference) learning curve of the particular data
set more closely. But even then the percentiles indicate that the
results are not reliable estimates of the learning curve of that
data set.
The cross validation of the real data set underestimates the
sensitivity for red blood cells for the extremely small sample
sizes, however the general development of sensitivity as func-
tion of the training sample size of the example run is correctly
reproduced. Also the learning curve for the leukocytes is quite
closely matched. For the BT-20 cells, however, the cross vali-
7
dation again does not even resemble the shape of the example
data set’s learning curve.
In conclusion, the average performances observed during
the iterated cross validation do not reliably recover the correct
shape of the learning curve of the particular data set for our
small sample size scenarios (middle rows), much less that of
the performance of any data set of the respective training sam-
ple size (top rows). In contrast, the actual performance of the
classifiers (top and middle rows) is acceptable to very good con-
sidering the actual training sample sizes: with 20 training cases
per class, red blood cells are almost perfectly recognized, sensi-
tivities around 0.90 are achieved for leukocytes and even about
2 out of 3 of the very difficult BT-20 breast cancer cells are
recognized correctly.
4. Sample Size Requirements for Classifier Testing
Thus, the precise measurement of the classifier performance
turns out to be more complicated in such small sample size sit-
uations. Sample size planning for classification therefore needs
to take into account also the sample size requirements for the
testing of the classifier. We will discuss here two important sce-
narios that allow estimating required test sample sizes: firstly,
specifying an acceptable width for a confidence interval of the
performance measure and secondly the number of test cases
needed for a comparison of classifiers.
4.1. Specifying Acceptable Confidence Interval Widths
## Loading required package: ggplot2
For Bernoulli processes, several approaches exist to estimate
confidence intervals for the true probability p given the ob-
served probability pˆ and the number of tests n, see [23, 24] for
recommendations particularly in small sample size situations.
For the following discussion, we use the Bayes method with a
uniform prior to obtain the minimal-length or highest posterior
density (HPD) interval [25, 26]. For details about the statis-
tical properties of this method, please refer to [24]. Package
binom[25] offers a variety of other methods that can easily be
used by the interested reader instead.
From a computational point of view, this method is con-
venient as the calculations can be formulated using the Beta-
distribution which allows to compute results not only for dis-
crete numbers of events k, but for real k. Thus, pˆ obtained from
testing many spectra can be used with a test sample size ntest
equalling e. g. the number of test patients or batches.
Confidence intervals for the true proportion are calculated
as function of the number of test samples (denominator of the
proportion) and the observed proportion pˆ. The intervals are
widest for pˆ = 0.5 and narrowest for pˆ = 0 or 1. Consequently,
the necessary test sample size to measure the performance with
a pre-specified precision can be calculated, either in a conser-
vative (worst-case) fashion for pˆ = 0.5 or using existing knowl-
edge/expectations about the achievable performance.
Figure 5 shows the 95 % confidence intervals for different ob-
served performances as function of the test sample size. For our
p^ = 0.75 p^ = 0.9 p^ = 0.95
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Figure 5: 95 % confidence intervals for different observed per-
formances pˆ as function of ntest. If 90 out of 100 samples of a
class are recognized correctly (e. g. sensitivity of the leukocytes
with 25 training samples), the 95 % confidence interval for the
sensitivity ranges from 0.83 to 0.94 – which in the context of
our classification task reads as being between “quite bad” and
“really good”.
example application, e. g. the sensitivity of the leukocyte class
reaches 0.90 rather quickly. If that model were tested with 100
leukocytes (i. e. four times as many as in our largest small data
sets) and 90 of them were correctly recognized, the 95 % con-
fidence interval would range from 0.83 (which would be con-
sidered quite bad as leukocytes are fairly easy to recognize) to
0.94 – which in the context of our classification task would be
translated to “quite good”. In other words, the confidence inter-
val would still be too wide to allow a practical judgment of the
classifier.
Similarly, already with 4 – 5 training spectra (out of 6 to-
tal red blood cell spectra in the data set), we observed perfect
recognition of red blood cells in the simulation example’s cross
validation. But the 95 % confidence interval still reaches down
to 0.65. However, for pˆ = 1 the confidence intervals narrow
very soon, and “already” with 58 test samples the lower limit of
the 95 % confidence interval reaches 0.95 (see fig. 6).
Figure 6 gives the width of the Bayesian confidence inter-
val as function of the test sample size for different observed
values of the performance. Note that specifying confidence in-
terval widths to be less than 0.10 with expected observed per-
formance between 0.90 and 0.95 already corresponds to requir-
ing between 3 – 5 12 times as many test samples as we consider
typically available in biospectroscopy. For confidence interval
widths of less than 0.05 which would allow to distinguish the
practical categories “bad” and “very good”, hundreds of test
cases are required. Also, this estimation of required sample
sizes is very sensitive to the true proportion p: if p were in
fact only 0.89 instead of the 0.9 assumed in the example, 153
instead of 141 test samples would be required to reach the spec-
ified confidence interval width.
4.2. Demonstrating that a New Classifier is Better
A second important scenario that allows to specify neces-
sary test sample sizes is demonstrating superiority to an already
known classifier. E. g., the instrument is improved and the re-
sulting advantage should be demonstrated. A rough estimate of
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Figure 6: 95 % confidence interval widths for different observed
performances pˆ as function of ntest. pˆ = 0.5 and 1 give the
widest and narrowest possible confidence interval widths. E. g.
If the confidence interval should not be more than 0.1 wide
while a sensitivity of 0.9 is expected, ntest ≥ 141 samples need
to be tested.
the performance of the new instrument is available. How many
samples are needed in order to prove the superiority of the new
approach?
From a statistics point of view, comparing classifier perfor-
mance is a typical hypothesis testing task. R package Hmisc
[27] provides functions for power (bpower) and sample size es-
timation (bsamsize) of independent proportions with unequal
test sample sizes as described by Fleiss et al. [28]. The ap-
proximation overestimates power for small sample sizes [29].
However, this is not of much consequence here, as the calcu-
lated sample sizes will anyways be rough guesstimates rather
than exact numbers of required samples: Firstly, the exact per-
formance of the improved classifier is unknown, so the sample
size planning needs to check the sensitivity of the calculated
numbers to this assumption. Secondly, the actual power of the
calculated scenario can be checked by bpower.sim.
Assume our recognition of BT-20 cells were improved from
the 0.75 sensitivity we obtain with 20 training samples / class to
0.90. A quick estimate of the necessary test sample size reveals
that in this scenario, the maximal obtainable power 1 (setting
ntest for the new model to 105 as infinite for practical purposes)
is 1 − β = 0.62. In other words, there is no chance to prove
the superiority of the new classifier with anything close to an
acceptable type II error2 due to the small test sample size avail-
able for the old model. The comparisons have most power if
the tests are performed with equal sample sizes. For this case,
tables are also available in Fleiss and Paik [30]. In our example,
the usual power of 0.8 (i. e. type II error β = 0.2; with type I
error3α = 0.05) needs at least 100 independent test cases truly
belonging to class bt for each of the models. Note that paired
tests can be much more powerful, thus requiring less samples.
Paired tests can be used when the same cases can be measured
1Probability that we correctly conclude that the new classifier is better than
the old one iff it actually is.
2Probability that we wrongly conclude the new classifier is no better than
the old one, although it actually is.
3Probability that we wrongly conclude the new classifier is better than the
old one, although it actually is not.
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Figure 7: Test sample size necessary to demonstrate superiority
of an improved model of sensitivity pnew, assuming the “old”
model had pold = 0.75 sensitivity and was tested with ntest = 25
samples and accepting a type I error of α = 0.05 and a type
II error β = 0.2 (solid line). Dotted: test sample size for the
second model with α = β = 0.10. However, if α = β = 0.05
is required (dashed), even a model with 0.975 true sensitivity
needs to be tested with at least 300 cases and 116 cases are
necessary to demonstrate the superiority of an improved model
truly achieving 0.99 sensitivity.
again (impossible for our study: new cell culture batches need
to be grown) or if the improvement is in the data analysis and
therefore the same instrumental data can be analysed by both
methods.
If we could achieve 0.975 sensitivity for BT-20 cells, we
would need to test with 63 test cases (accepting α = β = 0.10).
Figure 7 shows that this is very sensitive to the assumed qual-
ity of the new model: if the new model has in fact “only” a
sensitivity of 0.96 (corresponding to ca. 1 additional misclas-
sification out of 63 test cases), already 117 or almost twice as
many test cases are needed. Note that this is a rather extreme
example as it means one order of magnitude (0.25 to 0.025) re-
duction in the fraction of unrecognized BT-20 cells, which is
much larger than the improvements considered in the practice
of biospectroscopic classification.
In conclusion, well working classifiers need to be validated
with at least 75 test cases in order to obtain confidence inter-
vals that are narrow enough to draw practical conclusions about
the model. Demonstrating superiority of a new, improved clas-
sifier in general needs even more test cases and often will be
impossible at all if the test sample size for the old classifier was
small.
5. Summary
Using a Raman spectroscopic five class classification prob-
lem as well as simulated data based on the real data set, we
compared the sample sizes needed to train good classifiers with
sample sizes needed to demonstrate that the obtained classifiers
work well. Due to the smaller test sample size, sensitivities are
more difficult to determine precisely than specificities or overall
hit rates.
Using typical small sample sizes of up to 25 samples per
class, we calculated learning curves (sensitivity as function of
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the training sample size) using 100× iterated 5-fold cross vali-
dation. While the general shape of the learning curve could be
determined correctly for the very easily recognized red blood
cells, for more difficult recognition tasks not even the correct
shape of the learning curve can be determined reliably within
the small data set as the precise measurement of classifier per-
formance requires rather large test sample sizes (> 75 cases).
In consequence, we calculate necessary test sample sizes for
different pre-specified testing scenarios, namely specifying ac-
ceptable widths for the confidence interval of the true sensi-
tivity and the number of test samples needed to demonstrate
superiority of one classifier over another. In order to obtain
confidence interval widths ≤ 0.1, 140 test samples are neces-
sary when 90 % sensitivity is expected. In contrast, the recog-
nition of leukocytes in our example application reaches 90 %
sensitivity already with about 20 training samples. Comparison
of classifiers was found to require even larger test sample sizes
(hundreds of statistically independent cases) in the general case.
In conclusion, we recommend to start sample size planning
for classification by specifying acceptable confidence interval
widths for the expected sensitivities. This will lead to sample
sizes that allow retrospective calculation of learning curves and
a refined sample size planning in terms of both test and training
sample size can then be done.
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Supplementary file I: Confusion matrices for table 1
We give here the complete confusion tables for the models described in table 1. The counts are divided by the number of test
samples truly belonging to the respective class and averaged over all runs, i. e. the diagonal elements are the sensitivities, the other
entries are the specificities with respect to that particular misclassification.
Bayes Performance for Simulated Data LDA Model
conf.mat.bayes
## pred
## ref rbc leu mcf bt oci
## rbc 1 0 0.00 0.00 0.00
## leu 0 1 0.00 0.00 0.00
## mcf 0 0 0.95 0.03 0.02
## bt 0 0 0.04 0.91 0.05
## oci 0 0 0.02 0.03 0.94
n
## rbc leu mcf bt oci
## 40000 40000 40000 40000 40000
Bayes Performance for Simulated Data 10 latent variable PLS-LDA
conf.mat.plsbayes
## pred
## ref rbc leu mcf bt oci
## rbc 1 0.00 0.00 0.00 0.00
## leu 0 0.99 0.01 0.00 0.01
## mcf 0 0.00 0.87 0.06 0.07
## bt 0 0.00 0.14 0.72 0.13
## oci 0 0.00 0.04 0.09 0.86
n
## rbc leu mcf bt oci
## 40000 40000 40000 40000 40000
Average “Bayes” Performance for Real Data as used in the paper
confmat.bayes
## pred
## ref rbc leu mcf bt oci
## rbc 0.99 0.01 0.00 0.00 0.00
## leu 0.00 0.97 0.01 0.00 0.02
## mcf 0.00 0.00 0.91 0.04 0.05
## bt 0.00 0.00 0.13 0.75 0.13
## oci 0.00 0.01 0.04 0.07 0.89
n
## rbc leu mcf bt oci
## 372 569 558 532 518
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Average “Bayes” Performance for Real Data batch-wise validation
confmat.batch
## pred
## ref rbc leu mcf bt oci
## rbc 0.98 0.02 0.00 0.00 0.00
## leu 0.00 0.87 0.03 0.04 0.06
## mcf 0.00 0.00 0.33 0.37 0.30
## bt 0.00 0.00 0.32 0.38 0.30
## oci 0.00 0.02 0.31 0.36 0.31
n
## rbc leu mcf bt oci
## 372 569 558 532 518
This file is supplementary material for: C. Beleites, U. Neugebauer, T. Bocklitz, C. Krafft and J. Popp: Sample size planning for
classification models. Analytica Chimica Acta, 2013, 760 (Special Issue: Chemometrics in Analytical Chemistry 2012), 25–33,
DOI: 10.1016/j.aca.2012.11.007.
Supplementary file II: R code for section 4
Specifying Acceptable Confidence Interval Widths
Calculation of the Bayesian confidence intervals and their widths
require("binom")
require("ggplot2")
We consider test sample sizes up to 500:
n <- 1:500
Now calculate confidence intervals for different observed performance values pˆ between 0.5 and 1. As binom.bayes does not
converge for all combinations of n and pˆ, keep only results where the actual confidence level is 0.95 ±10−4 (a bunch of warnings will
be thrown; filter the results without adequate coverage afterwards). The uniform prior is selected by setting both prior.shape1
and prior.shape2 to 1.
confint <- lapply(c(0.5, 0.75, 0.9, 0.95, 0.975, 1), function(p) {
tmp <- binom.bayes(n = n, x = p * n, prior.shape1 = 1, prior.shape2 = 1)
tmp$phat <- p
subset(tmp, sig >= 0.05 - 1e-04 & sig <= 0.05 + 1e-04)
})
confint <- do.call(rbind, confint)
Add column containing the width of the confidence interval:
confint$width <- confint$upper - confint$lower
head(confint)
## method x n shape1 shape2 mean lower upper sig phat width
## 1 bayes 0.5 1 1.5 1.5 0.5 0.06083 0.9392 0.05 0.5 0.8783
## 2 bayes 1.0 2 2.0 2.0 0.5 0.09430 0.9057 0.05 0.5 0.8114
## 3 bayes 1.5 3 2.5 2.5 0.5 0.12275 0.8772 0.05 0.5 0.7545
## 4 bayes 2.0 4 3.0 3.0 0.5 0.14663 0.8534 0.05 0.5 0.7067
## 5 bayes 2.5 5 3.5 3.5 0.5 0.16681 0.8332 0.05 0.5 0.6664
## 6 bayes 3.0 6 4.0 4.0 0.5 0.18405 0.8159 0.05 0.5 0.6319
12
Sample sizes used in the text:
(nleuko <- min(subset(confint, phat == 0.9 & width <= 0.1)$n))
## [1] 141
(nery <- min(subset(confint, phat == 1 & width <= 0.05)$n))
## [1] 58
tmp <- binom.bayes(n = n, x = 0.89 * n, prior.shape1 = 1, prior.shape2 = 1)
tmp$width <- tmp$upper - tmp$lower
(nleuko89 <- min(subset(tmp, width <= 0.1)$n))
## [1] 153
95 % confidence interval for 90 correct out of 100 tested leukocytes:
binom.bayes(n = 100, x = 90, prior.shape1 = 1, prior.shape2 = 1)
## method x n shape1 shape2 mean lower upper sig
## 1 bayes 90 100 91 11 0.8922 0.8254 0.9444 0.05
95 % confidence interval for 6 correct out of 6 tested erythrocytes:
binom.bayes(n = 6, x = 6, prior.shape1 = 1, prior.shape2 = 1)
## method x n shape1 shape2 mean lower upper sig
## 1 bayes 6 6 7 1 0.875 0.6518 1 0.05
Generate the plots:
ggplot (subset (confint, phat %in% c (.75, .9, .95) & n <= 100)) +
geom_ribbon (aes (x = n, ymin = lower, ymax = upper), alpha = 0.25) +
facet_grid (. ~ phat, labeller = label_bquote(expr = hat (p) == .(x))) +
geom_line (aes (x = n, y = phat)) +
ylab ("p") + xlab (expression (n [test]))
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ggplot (subset (confint, width <= 0.2)) +
geom_line (aes (x = n, y = width, lty = as.factor (phat))) +
scale_linetype_discrete (expression (hat (p))) +
ylim (0, .2) + ylab ("95% confidence interval width") +
xlab (expression (n [test]))
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Demonstrating that a New Classifier is Better
require("Hmisc")
Assume our recognition of BT-20 cells were improved from the 75 % sensitivity we obtain with 20 training samples / class to
90 % (Bayes error for LDA of the simulated data). A quick estimate of the necessary test sample size reveals that in this scenario,
the maximal obtainable power (setting ntest for the new model to 105 as infinite for practical purposes) is 1 − β =
bpower.sim(p1 = 0.75, p2 = 0.9, n1 = 25, n2 = 1e+05, nsim = 1e+05)
## Power Lower Upper
## 0.6218 0.6188 0.6248
Required sample size for equal test sample sizes for both classifiers:
bsamsize(p1 = 0.75, p2 = 0.9)
## n1 n2
## 99.54 99.54
Prepare necessary sample size if old classifier was tested with 25 samples. bsamsize only accepts fractions of samples, not
directly specifying n1 = nold. Thus, we need to find the fraction that corresponds to nold = 25 and from there calculate nnew.
target.fun <- function(fraction, ..., n.old) {
n1 <- bsamsize(fraction = fraction, ...)[1]
(n1 - n.old)^2
}
est.n2 <- function(p2, ..., n.old) {
fraction <- optimize(target.fun, lower = 1e-05, upper = 0.5, ..., p2 = p2,
n.old = n.old)$minimum
ceiling(n.old/fraction - n.old)
}
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We consider p1 = 0.75, p2 ∈ [0.9, 1] and nold = 25 (target value for n1) for the three different type I and type II errors discussed
in the text:
p2 <- seq(0.9, 1, by = 0.001)
n2 <- sapply(p2, est.n2, power = 0.95, p1 = 0.75, n.old = 25)
df <- data.frame(p2 = p2, n2 = n2, power = 0.95)
n2 <- sapply(p2, est.n2, power = 0.9, alpha = 0.1, p1 = 0.75, n.old = 25)
df <- rbind(df, data.frame(p2 = p2, n2 = n2, power = 0.9))
n2 <- sapply(p2, est.n2, power = 0.8, p1 = 0.75, n.old = 25)
df <- rbind(df, data.frame(p2 = p2, n2 = n2, power = 0.8))
ggplot (data = subset (df, n2 <= 500), aes (x = p2, y = n2, lty = as.factor (power))) +
geom_line () + ylim (0, 500) + xlim (0.90, 1) +
xlab (expression (p [new])) + ylab (expression (n[test,~new]))
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The example values are extracted from the data.frame in the paper:
subset(df, p2 == 0.975 & power == 0.9, n2)
## n2
## 177 63
subset(df, p2 == 0.96 & power == 0.9, n2)
## n2
## 162 117
but can also be calculated directly with the functions defined above:
est.n2(p1 = 0.75, p2 = 0.975, power = 0.9, alpha = 0.1, n.old = 25)
## [1] 63
est.n2(p1 = 0.75, p2 = 0.96, power = 0.9, alpha = 0.1, n.old = 25)
## [1] 117
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